Health and Fitness Health and Fitness
Mon, October 11, 2010
[ Mon, Oct 11th 2010 ] - Market Wire
ImmunoGen, Inc. Announces Presentation of Encoura .. or Lorvotuzumab Mertansine at ESMO Annual Meeting
[ Mon, Oct 11th 2010 ] - Market Wire
ImmunoGen, Inc. Announces Updated Guidance for 2011 Fiscal Year
[ Mon, Oct 11th 2010 ] - Market Wire
30 am ET October 11, 2010 to Discuss New Collaboration and Updated Guidance for Fiscal Year 2011
[ Mon, Oct 11th 2010 ] - Market Wire
Alere Health Executives and Clients Share Insight .. gage Participants in Health and Wellness Programs
[ Mon, Oct 11th 2010 ] - Market Wire
ImmunoGen, Inc. Announces Collaboration for Rights to Use ImmunoGena?s TAP Technology
[ Mon, Oct 11th 2010 ] - Market Wire
Exelixis Licenses Programs to Bristol-Myers Squibb Company
Sun, October 10, 2010
[ Sun, Oct 10th 2010 ] - Market Wire
Aetna Announces New Managing Director Appointments in Asia Pacific
Sat, October 9, 2010
[ Sat, Oct 09th 2010 ] - Market Wire
ARYx Therapeutics Receives NASDAQ Notice of Non-Compliance
Fri, October 8, 2010
[ Fri, Oct 08th 2010 ] - Market Wire
Mintz Levin Represents Axsun Technologies Inc. in Trade Secret Victory
[ Fri, Oct 08th 2010 ] - Market Wire
ImmunoGen, Inc. Announces Positive Interim Result .. l Comparing Trastuzumab-DM1 vs. Standard First-Li
[ Fri, Oct 08th 2010 ] - Market Wire
Sanofi Pasteur and U.S. Department of Health and .. Into Agreement for Pandemic Vaccine Preparedness
[ Fri, Oct 08th 2010 ] - Market Wire
Thomas F. Cowhey to Lead Aetna Investor Relations
[ Fri, Oct 08th 2010 ] - Market Wire
Alnylam Scientists Present New Research on Expanded Delivery of RNAi Therapeutics
[ Fri, Oct 08th 2010 ] - Market Wire
Ligand Appoints Sunil Patel to Board of Directors
[ Fri, Oct 08th 2010 ] - Market Wire
Aetna Signs Three-Year Contract Extension with Grand View Hospital
[ Fri, Oct 08th 2010 ] - Market Wire
Universal Health Services, Inc. Announces Third Quarter 2010 Earnings Release and Conference Call
[ Fri, Oct 08th 2010 ] - Market Wire
Tenet to Release Third Quarter Results on Nov. 2, 2010
[ Fri, Oct 08th 2010 ] - Market Wire
Chemed to Report Third-Quarter 2010 Earnings Octo .. Related Conference Call to Be Held on October 26
[ Fri, Oct 08th 2010 ] - Market Wire
Cytori Therapeutics Proposes Common Stock Public Offering
[ Fri, Oct 08th 2010 ] - Market Wire
AngioDynamics Reports Fiscal 2011 First Quarter Financial Results
[ Fri, Oct 08th 2010 ] - Market Wire
PPD Opens New Office in Beijing, China
[ Fri, Oct 08th 2010 ] - Market Wire
Celera Says Case-Control Publication on KIF6 Does .. n KIF6a?s Association with Coronary Heart Disease
[ Fri, Oct 08th 2010 ] - Market Wire
Emergent BioSolutions Launches Singapore Operations
[ Fri, Oct 08th 2010 ] - Market Wire
Il presidente e fondatore di BioVitas Capital a" .. risultati positivi della fase IIa di plecanatide
[ Fri, Oct 08th 2010 ] - Market Wire
Apricus Bio Highlighted in Investment Newsletter
[ Fri, Oct 08th 2010 ] - Market Wire
Cytori Therapeutics Prices Public Offering of Common Stock
[ Fri, Oct 08th 2010 ] - Market Wire
???????,LifeCella" Stratticea" ??????????????????
Thu, October 7, 2010
[ Thu, Oct 07th 2010 ] - Market Wire
AmSurg Corp. to Broadcast 2010 Third Quarter Conference Call Live on the Internet
[ Thu, Oct 07th 2010 ] - Market Wire
Community Health Systems to Broadcast Third-Quarter 2010 Conference Call Live on the Internet
[ Thu, Oct 07th 2010 ] - Market Wire
Alexion Pharmaceuticals to Report Third Quarter Results on Thursday, October 21, 2010

Alexion Pharmaceuticals to Report Third Quarter Results on Thursday, October 21, 2010


Published on 2010-10-07 14:06:18 - Market Wire
  Print publication without navigation


CHESHIRE, Conn.--([ BUSINESS WIRE ])--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN), today announced that the Company will report its financial results for the third quarter ended September 30, 2010 on Thursday, October 21, 2010 before the financial markets open. Following the release of the financial results, Alexion management will conduct a conference call and audio web cast on Thursday, October 21, 2010, at 10:00 a.m. Eastern Time (ET).

To participate in this conference call, dial 719-457-2631, confirmation code 3490595 shortly before 10:00 a.m. ET. A replay of the call will be available from 2:00 p.m. ET through a limited time thereafter. The replay number is 719-457-0820, confirmation code 3490595. The audio web cast can be accessed at: [ www.alexionpharma.com ].

[ALXN-G]

Contributing Sources